Identification and specificity of broadly neutralizing antibodies against HIV
Laura E. McCoy, Dennis R. Burton · Immunological Reviews · 2017 · Review
Full textCC BY
Virology
Filters2 filters applied
Status
Year
Readable here
Study type
Licence
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
Andrew T. McGuire, Matthew D. Gray, Pia Dosenovic et al. · Nature Communications · 2016
Full textCC BY
Polyfunctional HIV-Specific Antibody Responses Are Associated with Spontaneous HIV Control
Margaret E. Ackerman, Anastassia Mikhailova, Eric P. Brown et al. · PLOS Pathogens · 2016
Full textCC BY
Human Monkeypox: Current State of Knowledge and Implications for the Future
Katy Brown, Peter Leggat · Tropical Medicine and Infectious Disease · 2016 · Review
Full textCC BY
Corrected Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
Joseph G. Jardine, Devin Sok, Jean-Philippe Julien et al. · PLOS Pathogens · 2016
Full textCC BY
CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
Rémi Fromentin, Wendy Bakeman, Mariam B. Lawani et al. · PLOS Pathogens · 2016
Full textCC BY
Release of gp120 Restraints Leads to an Entry-Competent Intermediate State of the HIV-1 Envelope Glycoproteins
Alon Herschhorn, Xiaochu Ma, Christopher Gu et al. · mBio · 2016
Full textCC BY
Coarse-grained simulation reveals key features of HIV-1 capsid self-assembly
John M. A. Grime, James F. Dama, Barbie K. Ganser-Pornillos et al. · Nature Communications · 2016
Abstract onlyCC BY
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
Timothée Bruel, Florence Guivel-Benhassine, Sonia Amraoui et al. · Nature Communications · 2016
Full textCC BY
Compartmentalized Replication of R5 T Cell-Tropic HIV-1 in the Central Nervous System Early in the Course of Infection
Christa Buckheit Sturdevant, Sarah B. Joseph, Gretja Schnell et al. · PLOS Pathogens · 2015
Full textCC BY
Review: Capripoxvirus Diseases: Current Status and Opportunities for Control
E. S. M. Tuppurainen, E. H. Venter, J. L. Shisler et al. · Transboundary and Emerging Diseases · 2015 · Review
Full textCC BY
Neuropathology of HAND With Suppressive Antiretroviral Therapy: Encephalitis and Neurodegeneration Reconsidered
Benjamin B. Gelman · Current HIV/AIDS Reports · 2015 · Review
Full textCC BY
The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins
Hasan Imam, Aalia Shahr Bano, Paresh Patel et al. · Scientific Reports · 2015
Full textCC BY
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst, Matthias Hoffmann, Matthew Pace et al. · Nature Communications · 2015 · Randomised trial
Full textCC BY
Chromatin organization at the nuclear pore favours HIV replication
Mickaël Lelek, Nicoletta Casartelli, Danilo Pellin et al. · Nature Communications · 2015
Full textCC BY
The Fitness Landscape of HIV-1 Gag: Advanced Modeling Approaches and Validation of Model Predictions by In Vitro Testing
Jaclyn K. Mann, John P. Barton, Andrew L. Ferguson et al. · PLoS Computational Biology · 2014
Full textCC BY
Comparison of Droplet Digital PCR and Seminested Real-Time PCR for Quantification of Cell-Associated HIV-1 RNA
Maja Kiselinova, Alexander O. Pasternak, Ward De Spiegelaere et al. · PLoS ONE · 2014
Full textCC BY
De novo Fatty Acid Biosynthesis Contributes Significantly to Establishment of a Bioenergetically Favorable Environment for Vaccinia Virus Infection
Matthew D. Greseth, Paula Traktman · PLoS Pathogens · 2014
Full textCC BY
Fatal Monkeypox in Wild-Living Sooty Mangabey, Côte d’Ivoire, 2012
Aleksandar Radonić, Sonja Metzger, Piotr Wojtek Dabrowski et al. · Emerging Infectious Diseases · 2014 · Case report
Full textCC BY
Tetramerization of SAMHD1 Is Required for Biological Activity and Inhibition of HIV Infection
Junpeng Yan, Sarabpreet Kaur, Maria DeLucia et al. · Journal of Biological Chemistry · 2013
Full textCC BY